DDJ Article • As of April 3, 2026
Staging and Grading in Periodontitis: How Reliable is the Classification, and What Does This Mean for Clinical Decision-Making?
The 2018 classification has established staging and grading as standard tools. However, prognostic validation lags behind clinical implementation—and promises of systemic therapy do not stand up to intervention evidence.
Orientation Before Reading
Critical Axes and Publication Limitations
- Article Type: Diagnosis/Classification. The topic is organized across five decision axes rather than a single global judgment.
- Evidence Basis: Grade A / Moderate Conclusion Strength / 8 rated studies (3 green, 5 yellow). This summary is written in clear clinical language.
- Bias Risk: Low to moderate. CoI Risk: Low. Source Integrity: sound.
- Guideline recommendations are partially based on moderate to low GRADE evidence; surgical indications are partly based on expert consensus.
Clinical Question
How reliable are staging and grading in periodontitis—and what does this specifically mean for treatment planning, prognosis assessment, and interdisciplinary decisions?
Executive Summary
The staging and grading system for periodontitis, introduced in 2018, has become an international clinical standard. It provides reproducible criteria for assessing severity and structures the treatment pathway from non-surgical initial therapy to surgical escalation. The EFP and BSP S3 guidelines support this framework with specific treatment recommendations. [1, 2, 7]
However, the prognostic validation—especially of the grading system—remains incomplete. Prospective studies demonstrating that Grade A, B, or C reliably predict different disease courses are lacking. In practice, this often leads to Grade B being assigned as a default, which can weaken the discriminatory power of the system. [1, 8]
The overall direction is benefit-oriented but not uniform: While staging and the stepwise treatment pathway are supported by solid evidence, the intervention evidence for systemic therapy effects—such as cardiovascular endpoint improvement—is very low. Therefore, DDJ reads the results not as an all-encompassing judgment, but along five clinical decision axes.
How DDJ Reads This Topic
DDJ treats this topic as a diagnosis and classification article. This means the question is not primarily whether periodontitis therapy works, but whether the diagnostic tool (staging/grading) reliably supports clinical decision-making.
The core conflict lies not in the general validity of the staging/grading system, but in its prognostic validation and practical applicability. At the same time, epidemiological associations—such as those between periodontitis and cardiovascular diseases—must be separated from intervention evidence.
Clinical questions, conflict zones, and consequences are what become visible.
Claim Clusters and Decision Axes
Claim Cluster 1 • Claims c01, c02
Staging: Assessing Severity and Complexity
Clinical Axis: How does the four-stage staging system classify severity, and what are the resulting implications for the treatment plan?
Why this axis matters: The correct stage assignment determines whether a patient requires primarily non-surgical treatment or needs surgical, regenerative, and interdisciplinary concepts.
Evidence Base: The staging system classifies periodontitis into four stages based on clinical attachment loss (CAL), radiographic bone loss, and tooth loss. Secondary complexity factors—probing depth over 6 mm, furcation involvement, tooth mobility—can elevate the stage. Stages I and II indicate initial to moderate periodontitis with a non-surgical focus; Stages III and IV denote advanced diseases that often require surgical and interdisciplinary treatment concepts. [1, 3]
Where the signal is stable: The primary staging criteria (CAL, bone loss, tooth loss) are reproducible and established in S3 guidelines.
Where uncertainty begins: Drawing the line between adjacent stages—especially between Stage II and III—requires clinical judgment. There is no direct validation study for staging criteria against clinical endpoints. Furthermore, cross-sectional studies show that practitioners with different educational backgrounds sometimes classify the same cases differently. [8]
Clinical Implication: Complexity factors must be systematically assessed before a stage is determined. Stage assignment is not an automatic calculation from individual values but an overall judgment incorporating all defined parameters.
Claim Cluster 2 • Claims c03, c04
Grading: Progression Risk and Its Limitations
Clinical Axis: How valid is the grading system (A/B/C) for assessing individual prognosis?
Why this axis matters: Grading guides recall frequency, treatment intensity, and communication regarding the individual risk profile. If the system does not differentiate validly, treatment decisions can be misguided.